77 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
1 Dec 22
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
4:26pm
as President of its Biologics Safety Testing Segment and its expectation that he will then assume the role of Maravai’s CEO in July 2023
Carl Hull … as President of Maravai’s Biologics Safety Testing Segment beginning December 5, 2022, and expects that Martin will assume the role of Chief Executive Officer
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
; and
Facility expansion plans to meet growing demand for Nucleic Acid Production and Biologic Safety Testing businesses.
"Maravai had an incredibly … % Change
Nucleic Acid Production
Biologics Safety Testing
Protein Detection
Total revenue
Six Months Ended June 30,
Year-over-Year % Change
Nucleic
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
2 Nov 22
Maravai Lifesciences Reports Third Quarter 2022 Financial Results
4:08pm
Biologics Safety Testing business, $48.4 million from our Nucleic Acid Production base business, and an estimated $126.5 million of COVID-19-related … Safety Testing
Protein Detection (sold in Sept. 2021)
Total Revenue
Nine Months Ended September 30,
Year-over-Year % Change
Nucleic Acid Production
8-K
EX-99.1
xejd4a5gy2 yc
2 Mar 21
Maravai Lifesciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance
4:18pm
8-K
EX-99.1
jalhz17ky
7 Nov 23
Maravai Lifesciences Reports Third Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
2ap0mpfn
10 Nov 21
Maravai Lifesciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance for 2022
4:09pm
S-1/A
EX-10.26
4r4txf1b z6ug
9 Nov 20
IPO registration (amended)
2:05pm
8-K
EX-99.1
x8vy25 gnz
4 Aug 22
Maravai Lifesciences Reports Second Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
lacd 0ywf6c
7 Aug 23
Maravai Lifesciences Reports Second Quarter 2023 Financial Results
4:19pm
8-K
EX-99.1
gfh8aa40g5 lgtamzb
27 Jul 23
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
4:11pm
8-K
EX-99.1
rdlqv15gkvwwo7cr
23 Feb 22
Maravai Lifesciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance
4:08pm
8-K
EX-99.1
kkgw18
8 May 23
Maravai Lifesciences Reports First Quarter 2023 Financial Results
4:09pm
10-K
1mm9u
22 Mar 21
Annual report
4:22pm
DRSLTR
um24p
14 Oct 20
Correspondence regarding draft registration statement
12:00am